The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Prospective non-randomized multi-center evaluation of the non-polymer based ACHIEVE™ Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study


1. Heart Center Siegburg, Siegburg, Germany; 2. University Hospitals of Leicester, Leicester, England; 3. Centro Cardiologico Monzino, Milan, Italy; 4. Clinique Saint Gatien, Tours, France; 5. Clinico San Carlos, Madrid, Spain; 6. Heart Center Bad Krozing

Background: The ACHIEVE™ Paclitaxel Eluting Coronary Stent System (CSS) is a non-polymeric paclitaxel coated stent loaded with a dose density of 3.0 µg/mm2 ste

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Impact of drug eluting stents on target vessel revascularization. A report from the Western Denmark heart registry from 2000 to 2004.